Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Electroconvulsive therapy in a patient with glaucoma.

Margaret S Good1, Tamara J Dolenc, Keith G Rasmussen

  • 1Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA.

The Journal of ECT
|April 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors Associated With Postictal Agitation After Electroconvulsive Therapy.

The journal of ECT·2021
Same author

The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine.

The Journal of clinical psychiatry·2019
Same author

Decreasing Treatment Duration of Electroconvulsive Therapy (ECT) Using Daily Right Unilateral Ultrabrief Instead of Bitemporal ECT.

Journal of psychiatric practice·2018
Same author

Effectiveness of Electroconvulsive Therapy in Patients With Major Depressive Disorder and Comorbid Borderline Personality Disorder.

The journal of ECT·2018
Same author

Corrigendum to "Continuation phase intravenous ketamine in adults with treatment-resistant depression" [J. Affect. Disord. 206 (2016) 300-304].

Journal of affective disorders·2017
Same author

Petitioning for Involuntary Commitment for Chemical Dependency by Medical Services.

The journal of the American Academy of Psychiatry and the Law·2017

Electroconvulsive therapy (ECT) may cause a small, temporary rise in intraocular pressure (IOP). This case study suggests ECT is likely safe for glaucoma patients, showing minimal IOP increase in a treated individual.

Area of Science:

  • Ophthalmology
  • Neurology
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) is known to cause transient elevations in intraocular pressure (IOP).
  • The safety of ECT in patients with glaucoma, particularly those with controlled disease, remains unclear.
  • This case report investigates IOP changes during ECT in a patient with pre-existing bilateral glaucoma.

Observation:

  • A patient with bilateral glaucoma, status post right eye surgery, underwent IOP monitoring during ECT.
  • Pre-treatment IOP was 16 mm Hg (right eye) and 18 mm Hg (left eye).
  • Following seizure induction, a transient ~5 mm Hg IOP increase was observed in the left eye, resolving within 5 minutes.

Findings:

  • The right eye exhibited negligible IOP change during the ECT-induced seizure.

Related Experiment Videos

  • The left eye showed a modest, short-lived IOP elevation.
  • The observed IOP changes were temporary and returned to baseline levels.

    • Implications:

    • ECT may be a relatively safe procedure for patients with medically or surgically controlled glaucoma.
    • Further research is warranted to confirm these findings in a larger glaucoma patient cohort undergoing ECT.
    • This case provides preliminary evidence supporting the cautious use of ECT in select glaucoma patients.